Our Company

Denome Technologies develops solutions to address constraints in existing genome wide expression techniques (RNA-sequencing and microarrays) including high cost, long execution and analysis time and requirement of trained manpower and expensive infrastructure.

Denome Technologies is capable of predicting expression levels of 8000 genes based on the expression level of Denome Core Genes (DCG) using Artificial Intelligence (AI) based machine learning algorithm. Denome prediction algorithm has been trained to uncover the connection between expression levels of different genes using the publically available RNA sequencing datasets. These RNA-seq data sets include 130k human and 170k mouse RNA-seq experiments. Analyses of various types of tissues leverage our system to work in any conditions such as specific treatments and genome editing.